Cellular proliferative activity was evaluated by the determination of 3H-thymidine labeling index (LI) in 20 specimens of human urologic malignancies (13 renal cell carcinomas and 7 transitional cell bladder carcinomas). Very low LI values were found in renal cell carcinomas, with a median value of 0.28%. Slightly higher proliferative activities were observed in bladder carcinomas, with a median LI value of 1.96%. No significant correlations were found between proliferative activity and pathologic stage or histologic grading in renal cell carcinomas. Although the number of bladder carcinomas evaluated does not allow any definite conclusion, an increase in LI values was found from in situ to invasive carcinoma and from tumors at stage I to tumors at stage III.
Get full access to this article
View all access options for this article.
References
1.
BaischH., OttoU., KonigK., KloppelG., KollermannM., LindenW.A.: DNA content of human kidney carcinoma cells in relation to histological grading.Br. J. Cancer, 45: 878–886, 1982.
2.
BaischH., BeckH.P., ChristensenI.J.: A comparison of mathematical methods for the analysis of DNA histograms obtained by flow cytometry.Cell Tissue Kinet., 15: 235–249, 1982.
3.
BassilB., DosoretzD.E., ProutG.R.Jr.: Validation of the tumor, nodes and metastasis classification of renal cell carcinoma.J. Urol., 134: 450–454, 1985.
4.
BeckH.P.: Evaluation of flow cytometric data of human tumors.Cell Tissue Kinet., 13: 173–181, 1980.
5.
BottigerL.E.: Prognosis in renal carcinoma.Cancer, 26: 780–787, 1970.
6.
BoxerR.J., WaismanJ., LieberM.M., MampasoF.M., SkinnerD.G.: Renal carcinoma: computer analysis of 96 patients treated by nephrectomy.J. Urol., 122: 598–601, 1979.
7.
CostaA., BonadonnaG., VillaE., ValagussaP., SilvestriniR.: Labeling index as a prognostic marker in non-Hodgkin lymphomas.J. Natl. Cancer Inst., 66: 1–5, 1981.
8.
De CarliA., La VecchiaC.: Cancer mortality in Italy, 1955–1978.Tumori (Supplement), 70: 581–742, 1984.
9.
DurieB.G.M., SalmonS.E., MoonT.E.: Pretreatment tumor mass, cell kinetics and prognosis in multiple myeloma.Blood, 55: 364–372, 1980.
10.
ElequinF.T., MuggiaF.N., GhosseinN.A., AgerP., KrishnaswamyV.: Correlation between in vitro labeling indices (LIs) and tumor regression following radiotherapy.Int. J. Radiat. Oncol. Biol. Phys., 4: 207–213, 1978.
11.
FriedellG.H., BellJ.R., BurneyS.W., SotoE.A., TiltmanA.J.: Histopathology and classification of urinary bladder carcinoma.Urol. Clin. North Am., 3: 53–70, 1976.
12.
GrabstaldH.: Renal cell cancer. Part I: Incidence, etiology, natural history and prognosis. N.Y.State J. Med., 64: 2539–2554, 1964.
13.
HarmerM.H. (ed.): U.I.C.C.-TNM Classification of human malignant tumors.3rd Edition, Geneva1978.
14.
HassanA., EzzatS., HegazyM., DahabaN., El BolkainiN., El BakiH.A., El MoneimH.A., MansourM., Aboul ElaM., El MeguidH.A., SaifIsmail: Cell proliferation in bilharzial bladder: influence of pre-operative irradiation and clinical implications.Int. J. Radiat. Oncol. Biol. Phys., 10: 2265–2272, 1984.
15.
HelpapB., SchwabeH.W., AdolphsH.D.: Proliferative pattern of urothelial bladder cancer and urothelial atypias.J. Cancer Res. Clin. Oncol., 109: 46–54, 1985.
16.
Histological typing of urinary bladder tumors. International Histological Classification of Tumors, Vol. 10, World Health Organization, Geneva, 1973.
17.
MostofiF.K.: Pathology and spread of renal cell carcinoma. In: Renal Neoplasia, KingJ.S.Jr. (ed.), Chpt. 3, pp. 41–85, Little Brown & Co., Boston, 1976.
18.
RabesH.M., CarlP., MeisterP., RattenhuberU.: Analysis of proliferative compartments in human tumors.I. Renal adenocarcinoma. Cancer, 44: 799–813, 1979.
19.
RobsonC.J., ChurchillB.M., AndersonW.: The results of radical nephrectomy for renal carcinoma.J. Urol., 101: 297–301, 1969.
20.
SilvestriniA., DaidoneM.G., GaspariniG.: Cell kinetics as a prognostic marker in node-negative breast cancer.Cancer, 56: 78–83, 1985.
